Hagen Brett R's Form 4 filing
Kalaris Therapeutics, Inc. (KLRS) · filed Jan 27, 2025
- Accession no.
- 0000950170-25-009204
- Filed
- Jan 27, 2025
- Trade date
- Jan 23, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $342.16. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hagen Brett RCIK 0001681782 | Officer (Chief Accounting Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 23, 2025 | Common Stock | SSaleDisposed | −32 | $9.45 | −$302.4 | 2,932 | Direct | |
| Jan 23, 2025 | Common Stock | SSaleDisposed | −4 | $9.94 | −$39.76 | 2,928 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.